Annual Congress Vienna 2012




Cystic fibrosis (adults and children): new aspects of risk factors, treatments and diagnosis

Poster Discussion
Chairs: N. Regamey (Bern, Switzerland), N. Simmonds (London, United Kingdom)


Download all media Download all media
 [+]  Congress or journal article abstract E-poster 3369 Lung function decline in a modern cystic fibrosis cohort
L. Welsh, L. King, P. Robinson, C. Robertson, S. Ranganathan (Melbourne, Australia)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract E-poster 3370 Is lung function worsening during adolescence in cystic fibrosis? A retrospective study
S. Volpi, A. Marostica, C. D‘Orazio, G. Amenta, E. Pintani, B. Assael (Verona, Italy)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract E-poster 3371 Comparative study of three quality of life instruments in adolescent and adults with cystic fibrosis
M. Cebrian, J. Ferrero, E. Ansotegui, A. Sole (Valencia, Spain)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 3372 Comparison of the Cystic Fibrosis Questionnaire with the St George‘s Respiratory Questionnaire in adult patients with cystic fibrosis
M. Hofer, A. Hirt, T. Kurowski, A. Boehler (Zurich, Switzerland)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 3373 Survival at low lung function in cystic fibrosis: Cohort study from 1995 to 2010
M. Osman, T. Daniels (Southampton, United Kingdom)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract E-poster 3374 The use of high frequency chest wall oscillation during an acute infective pulmonary exacerbation of cystic fibrosis
A. Banks, G. Davies, P. Agent, L. Osman, D. Bilton, M. Hodson (London, United Kingdom)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract E-poster 3375 Long inhalation time is associated with short treatment time when using the I-neb AAD system in target inhalation mode
T. Spencer, A. Black, N. Smith, K. Nikander, T. Dyche (Chichester, Portsmouth, United Kingdom; Parsippany, United States Of America)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract E-poster 3376 Long-term efficacy and safety of tobramycin 300mg/4mL nebuliser solution in patients with cystic fibrosis and chronic Pseudomonas aeruginosa infection
H. Mazurek, R. Chiron, G. Varoli, D. Santoro, H. Cicirello, Y. Antipkin (Rabka-Zdroj, Poland; Montpelier, France; Parma, Italy; Rockville, United States Of America; Kyiv, Ukraine)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract E-poster 3377 Pharmacokinetics of tobramycin nebulizer solution (300mg/4ml) administered by Pari e-Flow rapid vs Pari LC plus nebulizer in patients with cystic fibrosis and Pseudomonas aeruginosa infection
M. Govoni, G. Poli, H. Cicirello, D. Santoro, D. Acerbi, J. Ruzicka (Parma, Italy; Rockville, United States Of America; Bratislava, Slovakia)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 3379 Long-term linezolid in cystic fibrosis patients chronically colonized with Staphylococcus aureus (SA)
A. Sole, M. Cebrian, E. Ansótegui, E. Monte, E. Sanmartín, J.L. Perez (Valencia, Spain)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 3380 Allergic bronchopulmonary aspergillosis (ABPA) prevalence in adult cystic fibrosis (CF) patients. Usefulness of recombinant Aspergillus fumigatus IgE (rAsp f) in diagnosis and monitoring treatment
C. Navarro, M. Perez, D. Hernandez, E. Ansotegui, M. Cebrian, J. Peman, A. Sole (Valencia, Spain)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract E-poster 3381 Prevalence of tracheobronchomalacia in young children with cystic fibrosis
S. Poreddy, A. Withers, D. Cox, S. Stick (Subiaco, Australia)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract E-poster 3382 Oral health and some risk factors in children with cystic fibrosis
S. Mete, Y. Gokdemir, S. Peker, B. Karadag, B. Kargul (Istanbul, Turkey)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 3383 Active and passive smoking by CF patients in Belgium: A national survey
V. Godding, L. Stevens, P. Lebecque, L. Galanti (Bruxelles, Yvoir, Belgium)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 3384 Comparison of nanoduct versus macroduct sweat test for the diagnosis of cystic fibrosis in the newborn screening programme in Switzerland
J. Barben, C.S. Rueegg, S. Gallati, C.E. Kuehni, M. Baumgartner, T. Torresani, M.H. Schoeni, the Swiss CF Screening Group (St. Gallen, , Zurich, Switzerland)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite